Active, Not Recruiting
A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma
NCT04576117
- Conditions
- Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma, +2 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Loma Linda University Medical Center Loma Linda, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States